Cargando…

Refining risk assessment in cardiac sarcoidosis: a role for burden of late gadolinium enhancement and right ventricular function

Detalles Bibliográficos
Autores principales:	Murtagh, Gillian, Addetia, Karima, Patel, Amit, Laffin, Luke, Maffessanti, Francesco, Beshai, John F, Lang, Roberto, Mor-Avi, Victor, Patel, Amit R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045831/ http://dx.doi.org/10.1186/1532-429X-16-S1-P302

Ejemplares similares

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance
por: Murtagh, Gillian, et al.
Publicado: (2016)

Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
por: Addetia, Karima, et al.
Publicado: (2016)

Three-dimensional changes in regional right ventricular curvature and function in tetralogy of fallot
por: Cossor, Waseem, et al.
Publicado: (2015)

Inter-technique agreement between two-dimensional echocardiography and cardiovascular magnetic resonance imaging in the setting of bicuspid aortic valve disease
por: Vicedo, Beatriz Miralles, et al.
Publicado: (2014)

Influence of late gadolinium enhancement on left ventricular morphology and function in patients with sarcoidosis
por: Patel, Amit R, et al.
Publicado: (2009)

Alterations in regional right ventricular shape in patients following tetralogy of Fallot repair involving a transannular Patch
por: Singh, Amita, et al.
Publicado: (2016)

Quantification of the severity of tricuspid regurgitation from cardiac magnetic resonance cine images
por: Medvedofsky, Diego, et al.
Publicado: (2016)

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2012)

Right ventricle late gadolinium enhancement in cardiac sarcoidosis: a case series
por: Lydell, Carmen P, et al.
Publicado: (2011)

Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
por: Erley, Jennifer, et al.
Publicado: (2019)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Objective selection of short-axis slices for automated quantification of left ventricular size and function by cardiovascular magnetic resonance
por: Marino, Marco, et al.
Publicado: (2015)

Designing pulmonary arterial hypertension trials for detecting change in right ventricular function using cardiovascular magnetic resonance: what is the appropriate sample size?
por: Addetia, Karima, et al.
Publicado: (2013)

Late gadolinium enhancement and T2 MR imaging features of cardiac sarcoidosis involving the left and right ventricle
por: Cherian, Varghese, et al.
Publicado: (2009)

The role of late gadolinium enhancement of the right ventricular insertion point predicts survival in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2011)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement
por: Komada, Tomohiro, et al.
Publicado: (2016)

Value of late gadolinium enhancement by magnetic resonance in patients with cardiac sarcoidosis: characteristic findings and clinical utility
por: Watanabe, Eri, et al.
Publicado: (2009)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

RV dyssynchrony in PAH as evidenced by slice to slice minimum volume timing
por: Han, Qiao, et al.
Publicado: (2015)

Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
por: Kasai, Yufuko, et al.
Publicado: (2011)

Semi-quantitative assessment of resting perfusion in chronic myocardial infarction
por: Patel, Mita, et al.
Publicado: (2015)

Late Gadolinium Enhancement of the right ventricular myocardium: Is it really different from the left ?
por: Grosse-Wortmann, Lars, et al.
Publicado: (2008)

Vasodilator stress cardiovascular magnetic resonance imaging in post-orthotopic heart transplant recipients: evaluation of safety, hemodynamics, and myocardial perfusion
por: Narang, Akhil, et al.
Publicado: (2016)

Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance
por: Giusca, Sorin, et al.
Publicado: (2021)

Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure
por: MORRISSEY,, RYAN P, et al.
Publicado: (2010)

Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis
por: Tzogias, Leonidas, et al.
Publicado: (2009)

Using all-cause mortality to define severe RV dilation with RV/LV volume ratio
por: Altmayer, Stephan P. L., et al.
Publicado: (2018)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Myocardial strain analysis of the right ventricle: comparison of different cardiovascular magnetic resonance and echocardiographic techniques
por: Erley, Jennifer, et al.
Publicado: (2020)

Roadmap to the Mechanisms of Aortic Regurgitation on Echocardiography
por: Addetia, Karima, et al.
Publicado: (2020)

Right ventricular stress-induced perfusion defects and late gadolinium enhancement in coronary artery disease
por: Milks, Michael W, et al.
Publicado: (2014)

Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis(⋆)
por: Spence, Stewart, et al.
Publicado: (2018)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

CMR RV size assessment should include RV to LV volume ratio
por: Altmayer, Stephan P, et al.
Publicado: (2015)

Cardiac Sarcoidosis: A Picture May Be Worth a Thousand Words, But Do We Need More?
por: Patel, Amit R., et al.
Publicado: (2019)

Late gadolinium enhancement (LGE) progresses with right ventricle volume in children after repair of tetralogy of fallot()
por: Ylitalo, Pekka, et al.
Publicado: (2014)

Anomalous right coronary artery from the main pulmonary artery (ARCAPA): Incidental finding in an asymptomatic septuagenarian
por: Prabhu, Nicole, et al.
Publicado: (2023)

Editorial: Pulmonary sarcoidosis
por: Dhooria, Sahajal, et al.
Publicado: (2023)

The predictive role of right ventricular late gadolinium enhancement in patients with tetralogy of Fallot undergoing pulmonary valve replacement
por: Monti, Caterina Beatrice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t3t3kbsh02r9da2lbgg6jpttn0